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Introduction
In conjunction with the tremendous medical advances of the past century, an increasing number of hospitalized patients are dependent on parenteral fluids. Caring for children who have complex medical conditions has resulted in new challenges for prescribing parenteral therapy to maintain sodium and water homeostasis; most electrolyte disturbances occur in the hospital. Although the kidneys play an important role in the development of disorders in water handling, most of the morbidity and mortality results from central nervous system dysfunction (Table 1) . This review discusses common disorders of water metabolism, emphasizing the neurologic sequelae.
Hyponatremia
Hyponatremia is defined as a serum sodium level less than 135 mEq/L (135 mmol/L). It is one of the most common electrolyte disorders encountered in hospitals, occurring in approximately 3% of hospitalized children. The cause usually is identified easily, and the condition rarely is fatal, but sometimes the cause can be elusive and mortality can result from inappropriate therapy.
Pathogenesis
Under normal circumstances, the human body can maintain plasma sodium levels within the normal range (135 to 145 mEq/L [135 to 145 mmol/L]), despite wide fluctuations in fluid intake. The body's primary defense against developing hyponatremia is the kidney's ability to generate dilute urine and excrete free water. The primary reasons that children develop hyponatremia encompass underlying conditions that impair the kidney's ability to excrete free water (Table 2) . Hyponatremia usually occurs in the setting of excess water intake, with or without sodium losses, in the presence of impaired free water excretion. Only under the most extreme circumstances can excess water intake or sodium loss alone lead to hyponatremia in the absence of impaired free water excretion.
It is important to realize that the serum sodium concentration does not reflect total body sodium content accurately. Rather, a decrease in serum sodium more closely reflects an increase in total body water, and an increase in serum sodium reflects a free water deficit.
Diagnostic Approach
Before embarking on an aggressive therapeutic regimen, it is vital to confirm that hyponatremia is associated with hypo-osmolality. Hyponatremia can be associated with either a normal or an elevated serum osmolality (Fig. 1) . The most common causes are hyperglycemia, severe hyperproteinemia, or hyperlipidemia. Hyperglycemia results in hyperosmolality, with a translocation of fluid from the intracellular space to the extracellular space, resulting in a 1.6-mEq/L (1.6-mmol/L) decrease in levels of serum sodium for every 100 mg/dL (5.6 mmol/L) elevation in serum glucose concentration above normal. Severe hyperlipidemia and hyperproteinemia can cause a displacement of plasma water, which will result in a decreased sodium concentration (pseudohyponatremia) with a normal serum osmolality. Serum sodium levels currently are measured by either direct-or indirect-reading ionselective electrode potentiometry. The direct method will not indicate pseudohyponatremia because it measures the activity of sodium in the aqueous phase of serum only. The indirect method may indicate pseudohyponatremia because the specimen is diluted with a reagent prior to measurement. The indirect method is performed in approximately 60% of chemistry laboratories in the United States; therefore, pseudohyponatremia remains an entity of which clinicians must be aware. If hyponatremia is associated with hypoosmolality (true hyponatremia), the next step is to measure the urinary osmolality to determine if there is an impaired ability to excrete free water (urine Osm Ͼ100 mOsm/kg ).
The most useful information for correctly diagnosing hyponatremia is a detailed history of fluid balance, weight changes, medications (especially diuretics), and underlying medical illnesses. Hyponatremia usually is a multifactorial disorder, and a detailed history can identify sources of salt and water losses, free water ingestion, and underlying illnesses that prompt a nonosmotic stimulus for vasopressin production. Assessment of the volume status on physical examination and the urinary electrolytes on laboratory evaluation can be extremely helpful, but both findings can be misleading. For patients in whom hyponatremia is due to salt losses, such as from diuretics, signs of volume depletion may be absent on physical examination because the volume deficit may be nearly corrected by oral intake of hypotonic fluids if the thirst mechanism is intact.
In general, a urinary sodium concentration less than 25 mEq/L (25 mmol/L) is consistent with effective circulating volume depletion, and a concentration greater than 25 mEq/L (25 mmol/L) is consistent with renal tubular dysfunction, use of diuretics, or the syndrome of inappropriate antidiuretic hormone secretion (SIADH) (Fig. 1) . Numerous factors can affect the urine sodium, making interpretation difficult. Therefore, the timing of the urinary measurements in relation to dosages of diuretics, intravenous fluid boluses, or fluid and sodium restriction is important.
Clinical Manifestations
A major consequence of hyponatremia is influx of water into the intracellular space, resulting in cellular swelling that can lead to cerebral edema and encephalopathy. The clinical manifestations of hyponatremia are primarily neurologic and related to cerebral edema caused by hypo-osmolality (Table 3 ). The symptoms of hyponatremic encephalopathy vary substantially among individuals; the only consistent symptoms are headache, nausea, Children are at particularly high risk for developing symptomatic hyponatremia. They develop hyponatremic encephalopathy at higher serum sodium concentrations than do adults and have a poor prognosis if timely therapy is not initiated. This appears to be due to the higher brain-to-skull size ratio in children, which leaves less room for brain expansion (Fig. 2 ). Children's brains reach adult dimensions by 6 years of age, but the full skull size is not reached until 16 years of age. Also, animal data suggest that prepubertal children have an impaired ability to regulate brain cell volume due to diminished cellular sodium extrusion related to lower testosterone levels.
Hypoxemia is another major risk factor for developing hyponatremic encephalopathy. The occurrence of a hypoxic event, such as respiratory insufficiency, is a major factor militating against survival without permanent brain damage in patients who have hyponatremia. The combination of systemic hypoxemia and hyponatremia is more deleterious than is either factor alone because hypoxemia impairs the ability of the brain to adapt to hyponatremia, leading to a vicious cycle of worsening hyponatremic encephalopathy (Fig. 3) . Hyponatremia leads to decreased cerebral blood flow and arterial oxygen content. Patients who have symptomatic hyponatremia can develop hypoxemia by at least two different mechanisms: noncardiogenic pulmonary edema or hypercapnic respiratory failure. Respiratory failure can occur suddenly in patients who have symptomatic hyponatremia. Most of the neurologic morbidity reported for children who have hyponatremia has occurred in patients who have had a respiratory arrest as a feature of hyponatremic encephalopathy.
Of the many conditions that have been associated with hyponatremia, only a few are likely to lead to symptomatic hyponatremia.
SIADH
SIADH is one of the most common causes of hyponatremia in the hospital and frequently leads to severe hyponatremia (plasma sodium, Ͻ120 mEq/L [120 mmol/ L]). It is caused by elevated ADH secretion in the absence of an osmotic or hypovolemic stimulus. SIADH can be associated with a variety of illnesses, but most often it is due to central nervous system disorders, pulmonary disorders, and medications (Table 4) . Among the latter, the chemotherapeutic drugs vincristine and cyclophosphamide and the antiepileptic drug carbamazepine are especially common. SIADH is essentially a diagnosis of exclusion. Before it can be diagnosed, diseases causing decreased effective circulating volume, renal impairment, adrenal insufficiency, and hypothyroidism must be excluded. The hallmarks of SIADH are: mild volume expansion with low-to-normal plasma concentrations of creatinine, urea, uric acid, and potassium; impaired free water excretion with normal sodium excretion that reflects sodium intake; and hyponatremia that is relatively unresponsive to sodium administration in the absence of fluid restriction.
SIADH usually is of short duration and resolves with treatment of the underlying disorder and discontinuation of the offending medication. Fluid restriction is the cornerstone of therapy, but it represents a slow method of correction and frequently is impractical in infants who receive most of their nutrition in liquid form. All intravenous fluids should be of a tonicity of at least normal saline; if this does not correct the plasma sodium, 3% sodium chloride may be administered as needed. If more rapid correction of hyponatremia is needed, the addition of a loop diuretic in combination with hypertonic fluids is useful. Agents that produce diabetes insipidus, such as demeclocycline, can be used if SIADH persists for more than 1 month and is unresponsive to fluid restriction, increased sodium intake, and loop diuretics. Vasopressin 2 receptor antagonists are a promising therapy that are under investigation but are not approved for clinical use.
Postoperative Hyponatremia
Deaths due to hyponatremic encephalopathy have been reported in healthy children following routine surgical procedures. Patients develop hyponatremia postoperatively due to a combination of nonosmotic stimuli for ADH release, such as subclinical volume depletion, pain, nausea, stress, edema-forming conditions, and administration of hypotonic fluids. The postoperative nonosmotic stimuli for ADH release usually resolve by the third postoperative day, but they can persist until the fifth postoperative day. The most important factors leading to postoperative hyponatremia are failure to recognize the compromised ability of the patient to maintain water balance and the administration of hypotonic fluids. All postoperative patients should be considered at risk for developing hyponatremia, and prophylactic measures should include avoidance of hypotonic fluids and administration of normal saline unless a free water deficit is present. Serum electrolytes should be monitored postoperatively in patients receiving intravenous fluids, and physicians should be alert to signs of symptomatic hyponatremia. 
Oral Water Intoxication in Infants
Water intoxication is one of the most common causes of symptomatic hyponatremia in healthy infants; 70% of infants younger than 6 months of age who develop seizures that have no apparent cause are found to have hyponatremia due to water intoxication. Most of these infants are living in poverty and develop water intoxication when caregivers either dilute formula inappropriately or supplement feedings with water. Because an infant's caloric intake depends almost entirely on a liquid diet, hunger will drive the infant to accept a low-solute formula to the point of water intoxication. Infants typically present with generalized tonic-clonic seizures, respiratory insufficiency, and hypothermia. Affected infants may be managed with rapid and partial correction of hyponatremia via administration of hypertonic or normal saline. The hyponatremia corrects rapidly due to a free water diuresis, and it corrects spontaneously in many infants after they resume normal feeding. With appropriate treatment, the prognosis generally is good without long-term neurologic sequelae.
Diuretics
Diuretics are a relatively common cause of hyponatremia in children, with severe and symptomatic hyponatremia occurring primarily in patients receiving thiazide diuretics. Thiazide diuretics can cause both acute and chronic hyponatremia, but typically hyponatremia develops in the first few weeks following the initiation of therapy. Thiazide diuretics frequently are employed to manage edema-forming states, and the effects of the diuretic are synergistic with other underlying disorders that cause hyponatremia. Excess water intake also is a major contributing factor to the development of hyponatremia among those receiving diuretics.
Treatment
In general, if there are no neurologic manifestations of hyponatremia, correction with hypertonic saline is unnecessary and potentially harmful. Symptomatic hyponatremia, on the other hand, is a medical emergency. Once signs of encephalopathy are identified, prompt treatment is required in a monitored setting before imaging studies are performed. Fluid restriction alone has no place in the treatment of symptomatic hyponatremia. Affected pa- 
Cerebral Demyelination
Brain damage and cerebral demyelination can develop if there is an excessive change in serum sodium levels. Cerebral demyelinating lesions are a rare but recognized complication of therapy for hyponatremic encephalopathy. They typically occur several days following the correction of hyponatremia and can present with confusion, quadriplegia, pseudobulbar palsy, and a pseudocoma with a "locked in" stare. In many cases, they are asymptomatic. The lesions are diagnosed best on magnetic resonance imaging performed at least 2 weeks following the correction of hyponatremia. The incidence of cerebral demyelination is unclear because most reported cases failed to document the demyelination. Recent data demonstrated that the rate of correction has little or no relationship to the development of demyelinating lesions; rather, the absolute magnitude of correction and the underlying illnesses are the major contributing factors. Hyponatremic patients who develop demyelinating lesions have either: a) been made hypernatremic inadvertently, b) had their plasma sodium levels corrected by greater than 25 mmol/L in 24 to 48 hours, c) suffered a hypoxic event, or d) had severe liver disease. Because the risk of death and permanent neurologic damage in untreated hyponatremia far exceeds the theoretical possibility of demyelinating lesions following correction, clinicians should not hesitate to use hypertonic saline in symptomatic patients.
Hypernatremia
Hypernatremia is defined as a serum sodium concentration greater than 145 mEq/L (145 mmol/L). In both children and adults, hypernatremia is seen primarily in hospitals and occurs in individuals who have restricted access to water for a variety of reasons. Typically, affected patients are either debilitated by an acute or chronic illness, have neurologic impairment, or are at the extremes of age. Infants, especially those born preterm, are at particularly high risk for the development of hypernatremia because of their relatively small mass-to-surface area ratio and their dependency on a caretaker to administer fluids. Gastroenteritis remains an important cause of hypernatremia in children, but it is much less common than previously reported. Ineffective breastfeeding is a rare cause of hypernatremia, but the incidence appears to be increasing. It primarily occurs in primiparous welleducated mothers, who fail to recognize progressive malnutrition and dehydration. Significant vascular complications have been reported in these infants. Unlike mild chronic hyponatremia, which may be physiologic in certain edematous diseases, a serum sodium concentration greater than 145 mEq/L (145 mmol/L) always should be considered abnormal and evaluated thoroughly.
Pathogenesis
The body has two defenses to protect against developing hypernatremia: the ability to produce a concentrated urine and a powerful thirst mechanism. ADH release occurs when the plasma osmolality exceeds 275 to 280 mOsm/kg (275 to 280 mmol/kg) and results in a maximally concentrated urine when the plasma osmolality exceeds 290 to 295 mOsm/kg (290 to 295 mmol/ kg). Thirst is the body's second line of defense, but it provides the ultimate protection against hypernatremia. If the thirst mechanism is intact and access to free water is unrestricted, it is rare for a person to develop sustained hypernatremia from either excess sodium ingestion or a renal concentrating defect.
Excess water intake is a major contributing factor to the development of hyponatremia among those receiving diuretics.
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Hypernatremia is usually multifactorial, and a systematic approach is required to determine the contributing factors (Fig. 4) . Serum sodium, glucose, and osmolality levels must be measured. An elevated serum sodium concentration always is associated with hyperosmolality and should be considered abnormal. In cases of significant hyperglycemia, the serum sodium concentration will be depressed due to the associated translocation of fluids from the intracellular to extracellular space. Once hypernatremia has been diagnosed, a detailed history should be taken and fluid intake reviewed to determine if the patient has an intact thirst mechanism, has restricted access to fluids, or is not being provided adequate free water in intravenous fluids. Urine volume should be measured and compared with fluid intake, and the urine osmolality and electrolyte levels should be determined to assess if the renal concentrating ability is appropriate and to quantify the urinary free water losses. A less than maximally concentrated urine (Ͻ800 mOsm/kg [800 mmol/L]) in the face of hypernatremia is a sign of a renal concentrating defect because hypernatremia is a maximal stimulus for ADH release. For patients who have hypernatremia, the following should be evaluated: gastrointestinal losses, dermal losses from fever or burns, diet history (including enteral feedings), medication history (including diuretics), and sources of exogenous sodium.
Clinical Manifestations and Mortality
Hypernatremia results in an efflux of fluid from the intracellular space to the extracellular space to maintain osmotic equilibrium. This leads to transient cerebral dehydration and cell shrinkage. Brain cell volume can decrease by as much as 10% to 15% acutely, but it adapts quickly. Within 1 hour, the brain significantly increases its intracellular content of sodium and potassium, amino acids, and unmeasured organic substances (idiogenic osmoles). Within 1 week, the brain regains approximately 98% of its water content. If severe hypernatremia develops acutely, the brain may not be able to increase its intracellular solute sufficiently to preserve its volume, and the resulting cellular shrinkage can cause structural changes. Cerebral dehydration from hypernatremia can result in a physical separation of the brain from the meninges, leading to rupture of the delicate bridging veins and intracranial or intracerebral hemorrhages. Venous sinus thrombosis progressing to infarction also can develop. Acute hypernatremia also has been shown to cause cerebral demyelinating lesions in both animals and humans. Patients who have hepatic encephalopathy are at the highest risk for developing such lesions. Children who have hypernatremia usually appear agitated and irritable, but these symptoms can progress to lethargy, listlessness, and coma. Neurologic examination frequently reveals increased tone, nuchal rigidity, and brisk reflexes. Myoclonus, asterixis, and chorea can be present; tonic-clonic and absence seizures have been described. Hyperglycemia is a particularly common consequence of hypernatremia in children. Severe hypernatremia also can result in rhabdomyolysis. Although earlier reports showed that hypocalcemia was associated with hypernatremia, this has not been found in more recent literature.
Hypernatremia is associated with a mortality rate of 15% in children, which is estimated to be 15 times higher than the age-matched mortality in hospitalized children who do not have hypernatremia. The high mortality rate is unexplained. Most of the deaths are not related directly to central nervous system pathology and appear to be independent of the severity of hypernatremia. Recent studies have noted that patients who develop hypernatremia following hospitalization and patients in whom treatment is delayed have the highest mortality. Approximately 40% of the deaths in children occurred while patients were still hypernatremic.
Treatment
The goal of therapy for hypernatremia is to correct both the serum sodium level and the circulatory volume. The cornerstone is provision of adequate free water to correct the serum sodium level. The free water deficit cannot be assessed easily by physical examination in children who have hypernatremic dehydration because most of the water losses are intracellular. Accordingly, the signs of volume depletion are less pronounced due to better preservation of the extracellular volume. A simple method of estimating the minimum amount of fluid necessary to correct the serum sodium is by the following equation:
Free water deficit (mL) ϭ 4 mL ϫ lean body weight (kg) ϫ [desired change in serum sodium mEq/L (mmol/L)] Larger amounts of fluid will be required, depending on the fluid composition. To correct a 3-L free water deficit, approximately 4 L of 0.2% sodium chloride in water or 6 L of 0.45% sodium chloride in water would be required because they contain approximately 75% and 50% free water, respectively. The calculated deficit does not account for insensible losses or ongoing urinary or gastrointestinal losses. Maintenance fluids, which include replacement of urine volume with hypotonic fluids, are given in addition to the deficit. If there are signs of circulatory collapse, fluid resuscitation with normal saline or colloid should be instituted before correcting the free water deficit. The type of therapy depends largely on the cause of the hypernatremia and should be tailored to the pathophysiologic events involved in each patient (Table 5 ). Oral hydration should be instituted as soon as it can be tolerated safely. Plasma electrolytes should be measured every 2 hours until the patient is neurologically stable.
The rate of correction of hypernatremia depends largely on the severity of hypernatremia and its cause. Due to the relative inability of the brain to extrude idiogenic osmoles, rapid correction of hypernatremia can lead to cerebral edema. Although no definitive studies document the optimal rate of correction that can be undertaken without developing cerebral edema, empiric data have shown that unless symptoms of hypernatremic encephalopathy are present, a rate of correction not exceeding 1 mEq/h or 15 mEq/24 h is reasonable. In severe hypernatremia (sodium, Ͼ170 mEq/L [170 mmol/L]), serum sodium should not be corrected to below 150 mEq/L (150 mmol/L) in the first 48 to 72 hours. It is not uncommon for seizures to occur during the correction of hypernatremia; they may be a sign of cerebral edema. They usually can be managed by slowing the rate of correction or by administering hypertonic saline to increase the serum sodium concentration slightly. The seizures are usually self-limited and not a sign of long-term neurologic sequelae. Patients who have acute hypernatremia that is corrected by the oral route can tolerate a more rapid rate of correction with a much lower incidence of seizures.
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